Decisions for older adults (aged ≥65 years) and their clinicians about cancer screening are not easy. The evidence of benefits is unclear and the chance of harm becomes greater (eg, overdiagnosis, burdens of additional testing, false-positive results, and psychological impacts),
1-3 which can adversely impact an older individual’s remaining quality of life.
4-7 Although guidelines recommend when screening is no longer needed (eg, life expectancy <10 years for breast screening),
8 many older people with limited life expectancy continue screening for colorectal, breast, cervical, and prostate cancer.
9,10